BAD anticorps (pSer155, Ser155) (Biotin)

N° du produit ABIN6754782

Cet anticorps anti-BAD est un anticorps Souris Monoclonal détectant BAD dans WB et ELISA. Adapté pour Humain.

Aperçu rapide pour BAD anticorps (pSer155, Ser155) (Biotin) (ABIN6754782)

Antigène: BAD (BCL2-Associated Agonist of Cell Death (BAD))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp BAD est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA

Détail du produit anti-BAD anticorps (Biotin)

Épitope: pSer155, Ser155

Specificité: Human BAD

Réactivité croisée: Souris

Purification: Affinity purified

Immunogène: KLH-conjugated synthetic phosphopeptide around Ser155 region of mouse Bad.
ImmunogenType: Synthetic phospho-peptide

Isotype: IgG1

Information d'application

Indications d'application: The applications listed above are for the unconjugated form of this antibody. The conjugated antibody has not been tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.2, 0.09% sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: 4 °C

Stockage commentaire: May be stored at 4°C for short-term only. Store at -20°C. Aliquots are stable for at least 6 months.

Détails sur BAD

Antigène: BAD (BCL2-Associated Agonist of Cell Death (BAD))

Autre désignation: BAD

Sujet: Synonyms: BAD, BBC2, Bcl-2-like protein 8, BCL2-binding component 6, BCL2L8, BBC6, BCL-X/BCL-2 binding protein, Bcl-2-binding component 6, Bcl2 antagonist of cell death, BCL2-binding protein, Bcl2-L-8

ID gène: 572

Pathways: Signalisation MAPK, Signalisation PI3K-Akt, Signalisation RTK, Apoptose, Fc-epsilon Receptor Signaling Pathway, Positive Regulation of Peptide Hormone Secretion, Carbohydrate Homeostasis, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Hepatitis C, CXCR4-mediated Signaling Events